相关实验视频

Updated: Jun 4, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

通过基因代码扩展系统,为基于CAR的细胞免疫疗法设计可控制和可逆的开关

Yue Liu^1,2, Lingna An^1,2, Xiaoqi Wang^1,2

¹Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, 400037, China.

Journal of hematology & oncology

|December 19, 2024

概括

这项研究引入了一种使用非自然氨基酸 (BOCK) 控制CAR-T细胞治疗的新方法. 该系统允许精确调节CAR-T细胞活动,提高对瘤的安全性和有效性.

科学领域:

生物技术是生物技术.
免疫治疗是一种免疫疗法.
合成生物学合成生物学

背景情况:

化学抗原受体T (CAR-T) 细胞疗法对血液瘤有前途,但面临毒性和复发等挑战.
目前的CAR-T疗法缺乏对蛋白质表达和功能的精确控制,这限制了其安全性和有效性.
对于提高CAR-T细胞疗法的可控性和安全性的策略至关重要.

研究的目的:

为可控制的CAR蛋白表达和调节设计一个遗传密码扩展系统.
研究使用非自然氨基酸BOCK作为控制CAR-T细胞功能的开关.
为了评估这种BOCK诱导系统的安全性和有效性,在体外和体内.

主要方法:

设计了一种使用非自然氨基酸BOCK调节CAR蛋白转换的遗传密码扩展系统.
开发了一个系统,其中CAR蛋白表达在没有BOCK的情况下是"关闭的",在BOCK的情况下是"开放的".
进行了体外和体内实验,以评估CAR-T细胞功能和抗瘤活性.

主要成果:

验证了BOCK诱导系统作为蛋白质表达的可控制开关.
通过BOCK证明精确控制CAR蛋白表达和CAR-T细胞信号激活.
在小鼠模型中展示了对瘤细胞的CAR-T细胞细胞毒性的剂量依赖调节和显著的抗瘤作用.
证实了用于控制NK细胞抗瘤活性的BOCK诱导装置的普遍性.

结论:

由BOCK诱导的遗传密码扩展系统精确地调节CAR蛋白的表达,并控制CAR-T细胞的抗瘤作用.
这种可控制和可逆的开关为基于CAR的更安全,更有效的免疫疗法提供了潜力.
该系统有望增强基于CAR的细胞免疫疗法的临床应用.

关键词:

这是一本书,一本书.基于CAR的细胞免疫疗法可控和可逆的可控和可逆的基因代码扩展系统的基因代码扩展系统.开关开关开关开关开关

更多相关视频

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Production of Human CRISPR-Engineered CAR-T Cells

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

相关概念视频

Conservative Site-specific Recombination and Phase Variation

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...

Methods of Nuclear Reprogramming

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...